Walon L, Gilbeau C, Lachapelle J-M
Service de Dermatologie de l'Université Catholique de Louvain, 30 Clos Chapelle-aux-champs, UCL 3033, B-1200, Bruxelles, Belgique.
Ann Dermatol Venereol. 2003 Apr;130(4):443-6.
Many drugs may induce acneiform eruptions: vitamine B12, corticosteroids, androgens, lithium, tuberculostatics, halogens, some antidepressants, anticonvulsives and immunosuppressors. Many cases of acneiform eruptions can be observed following treatment with cetuximab, a drug used for solid cancers at advanced stages in experimental protocols.
Case 1. A 56 year-old woman, suffering from a colorectal cancer, developed a sudden acneiform eruption after 6 cures of cetuximab, at a one-week interval. She was treated with bisoprolol hemifumarate, sodium levothyroxin, cyproterone acetate and estradiol valerate. Clinical examination revealed inflammatory and follicular papulopustules localized on the face and upper chest. Comedos were absent. Itching sensations were discrete. Histopathological examination of a papulopustule revealed a folliculitis with polymorphonuclear neutrophils. PAS staining did not reveal the presence of bacteria or yeasts. Bacterial and fungal cultures were negative. Lesions faded in approximately 2 weeks following minocycline treatment (100 mg/day). Case 2. A 65 year-old man, treated by cetuximab for a colorectal adenocarcinoma, suddenly developped follicular inflammatory papulopustules on the face, trunk and extensor surfaces of both arms, after 3 weeks of treatment. Itching was discrete. Comedos were absent. Histopathology revealed the presence of a folliculitis with polymorphonuclear neutrophils. Bacteriology and mycology were negative. Lesions were partly controlled by administration of minocycline (100 mg/day) but worsened again in the days following each cure of cetuximab.
Cetuximab is a monoclonal antibody binding to the epidermal-growth-factor-receptor. It is used in the treatment of solid cancers at advanced stages. Both case reports share some similarities: the development of follicular inflammatory papulopustules distributed on the face and trunk typical, of acneiform drug eruptions. Itching is discrete. Comedos are absent. Quick onset of lesions is the rule. Cetuximab can be added to the list of drugs responsible for acneiform eruption.
许多药物可诱发痤疮样皮疹,包括维生素B12、皮质类固醇、雄激素、锂盐、抗结核药、卤素、某些抗抑郁药、抗惊厥药和免疫抑制剂。在实验方案中,用于治疗晚期实体癌的西妥昔单抗治疗后,可观察到许多痤疮样皮疹病例。
病例1。一名56岁患有结肠直肠癌的女性,在每隔一周接受6次西妥昔单抗治疗后,突然出现痤疮样皮疹。她正在接受富马酸比索洛尔、左甲状腺素钠、醋酸环丙孕酮和戊酸雌二醇治疗。临床检查发现炎症性和毛囊性丘疹脓疱局限于面部和上胸部。无粉刺。瘙痒感不明显。对一个丘疹脓疱进行组织病理学检查显示为伴有多形核中性粒细胞的毛囊炎。PAS染色未显示细菌或酵母的存在。细菌和真菌培养均为阴性。米诺环素治疗(100毫克/天)后约2周皮疹消退。病例2。一名65岁男性,因结肠腺癌接受西妥昔单抗治疗,在治疗3周后,面部、躯干和双臂伸侧突然出现毛囊炎性丘疹脓疱。瘙痒不明显。无粉刺。组织病理学显示存在伴有多形核中性粒细胞的毛囊炎。细菌学和真菌学检查均为阴性。米诺环素(100毫克/天)给药部分控制了皮疹,但在每次西妥昔单抗治疗后的几天内皮疹再次加重。
西妥昔单抗是一种与表皮生长因子受体结合的单克隆抗体。它用于治疗晚期实体癌。两个病例报告有一些相似之处:面部和躯干出现典型的毛囊炎性丘疹脓疱,这是痤疮样药疹的表现。瘙痒不明显。无粉刺。皮疹通常起病迅速。西妥昔单抗可被列入诱发痤疮样皮疹的药物名单。